POP Biotechnologies Announces Phase 3 Trial Interim Results Published for COVID-19 Vaccine Based on POP BIO SNAP(TM)

September 27, 2024 2:00 PM

BUFFALO, NY / ACCESSWIRE / September 27, 2024 / POP Biotechnologies (POP BIO), a Buffalo, NY-based biopharmaceutical company, is pleased to announce the publication of positive findings in a peer-reviewed paper in the Journal of Medical Virology entitled "Interim safety and immunogenicity analysis of the EuCorVac-19 COVID-19 vaccine in a Phase 3 randomized, observer-blind, immunobridging trial in the Philippines".EuCorVac-19EuCorVac-19, a...

Read more

Global Healthcare Leaders Foundation (GHLF) Introduces Membership Program with the Launch of Its First Tier - Founding Members

September 27, 2024 1:00 PM

The Global Healthcare Leaders Foundation (GHLF) is launching its exclusive Membership Program, beginning with the introduction of its first tier: the Founding Members. This program is designed to unite a diverse network of healthcare professionals and experts from around the world. It is more than a typical network; it is a platform for genuine connection, collaboration, and a shared commitment to advancing patient care on a global scale. The...

Read more

MasterWord and UNESCO Join Forces to Preserve and Digitize Mayan Languages for Future Generations

September 27, 2024 12:15 PM

HOUSTON, TX / ACCESSWIRE / September 27, 2024 / MasterWord is honored to announce its partnership with UNESCO, within its actions linked to multilingualism online (2003 Recommendation concerning the Promotion and Use of Multilingualism and Universal Access to Cyberspace) and the International Decade of Indigenous Languages (IDIL 2022-2032), in advancing the preservation of the linguistic and cultural heritage of Mayan speakers through the Mayan...

Read more

Sorevna Introduces Revolutionary All-Natural Skin Cream for Tough Calluses and Dry Skin

September 27, 2024 12:15 PM

Sorevna, a leader in natural skincare solutions, proudly announces the launch of its innovative all-natural cream, designed to address even the toughest calluses and extremely dry skin. This groundbreaking formula offers a gentle yet effective solution for a wide range of individuals, from those with occupational skin concerns to those managing specific skin conditions.A Natural Solution for Diverse NeedsSorevna's new cream is formulated to meet...

Read more

Hyivy Health Secures $2M Seed to Unlock New Model for Treating Pelvic Pain

September 27, 2024 10:00 AM

Pelvic health startup Hyivy Health poised to offer better solutions to the 300M patients with pelvic floor dysfunction causing chronic pelvic pain and the clinicians who treat them.KITCHENER, ON / ACCESSWIRE / September 27, 2024 / FemTech startup Hyivy Health has raised $2 million in their latest seed funding round from private investors to advance the Hyivy Pelvic Health Rehabilitation System, which stands to replace the current standard of...

Read more

Patients for Patient Safety US Applauds the Biden-Harris Administration for Prioritizing Patient Safety

September 27, 2024 9:30 AM

WASHINGTON, DC / ACCESSWIRE / September 27, 2024 / On September 17th, World Patient Safety Day (WPSD), the Biden-Harris Administration announced new actions to improve patient and workforce safety during a White House Healthcare Safety Forum. These actions include commitments made by Patients for Patient Safety US (PFPS US) and others in government and private sector organizations, rounding out a year of federal leadership actions recognizing...

Read more

Lexaria Receives Independent Review Board Approval to Begin Human Pilot Study #3

September 27, 2024 9:20 AM

Lexaria Bioscience Corp. (NASDAQ:LEXX)(NASDAQ:LEXXW) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms is pleased to announce that approval has been received from an independent review board, for human pilot study #3 (the "Study"), investigating a DehydraTECH-processed version of the dual action GLP-1 (glucagon-like peptide) + GIP (glucose-dependent insulinotropic peptide) tirzepatide in an oral dose format.Subject...

Read more

Introducing Compassion Center Austin: Pioneering Natural Wellness Solutions Through the Texas Compassionate Use Program (TCUP)

September 27, 2024 8:00 AM

Compassion Center Austin introduces Texans to natural pain management and opioid risk reduction through the Texas Compassionate Use Program (TCUP). By integrating low-THC cannabis and endocannabinology into the continuum of care, the Compassion Center offers a holistic approach to improving biophysical wellness, mental health, and spiritual well-being. Compassion Center Austin is committed to empowering patients with innovative, plant-based...

Read more

Humaneva Group Secures Major US Private Equity Investment to Accelerate Global Clinical Research Market Expansion

September 27, 2024 7:45 AM

WARSAW, POLAND / ACCESSWIRE / September 27, 2024 / Humaneva Inc. has entered into a significant investment agreement with Viking Global Investors, a global investment firm based in the United States ("Viking"). Under this agreement, Viking acquired a minority stake in Humaneva Inc., a spin-off of NEUCA S.A, for $50M. In addition, Viking has been granted a one-year option to invest an additional $50M in Humaneva Inc. This collaboration will play...

Read more

MIRA Pharmaceuticals Announces New Preclinical Data for Ketamir-2 to Be Presented at the 18th Annual Pain Therapeutics Summit in Boston on October 28-29, 2024

September 27, 2024 7:30 AM

Conference presentation delivers preclinical results demonstrating Ketamir-2 achieves 100% reversal of neuropathic painMIAMI, FL / ACCESSWIRE / September 27, 2024 / MIRA Pharmaceuticals, Inc. (NASDAQ:MIRA), a preclinical-stage pharmaceutical company developing innovative therapies for neurologic and neuropsychiatric disorders, today announced that new preclinical data on its lead development product, Ketamir-2, will be presented at the 18th...

Read more

Notice of Extraordinary General Meeting in Senzime AB (publ)

September 27, 2024 7:30 AM

The shareholders in Senzime AB (publ)(STO:SEZI)(OTCQX:SNZZF) corp. reg. no 556565-5734 (the "Company") are hereby convened to an extraordinary general meeting on 23 October 2024 at 10.00 at Advokatfirman Lindahl's premises on Vaksalagatan 10 in Uppsala.Notice etc.Shareholders who wish to participate in the general meeting must:- be registered in the share register kept by Euroclear Sweden AB on Tuesday 15 October 2024 (the record date), and-...

Read more

Hemogenyx Pharmaceuticals PLC Announces Half-year Report

September 27, 2024 2:00 AM

Hemogenyx Pharmaceuticals plc (LSE:HEMO), the biopharmaceutical group developing therapies designed to transform blood disease treatment, whose shares are admitted to the equity shares (transition) category of the Official List, announces its unaudited interim results for the six-month period ended 30 June 2024.All financial amounts are stated in GBP British pounds unless otherwise indicated.Key HighlightsThe U.S. Food and Drug Administration...

Read more

Aytu BioPharma Reports Fiscal 2024 Full Year and Fourth Quarter Operational and Financial Results

September 26, 2024 4:15 PM

Full year fiscal 2024 consolidated net revenue of $81.0 million; Rx Segment net revenue of $65.2 millionFull year fiscal 2024 ADHD Portfolio net revenue up 23% compared to fiscal 2023Full year fiscal 2024 adjusted EBITDA1 improved to $9.2 million, up by $5.7 million compared to fiscal 2023$20.0 million cash balance at June 30, 2024Company expects Rx Segment net revenue and adjusted EBITDA growth in fiscal 2025 from current levelsCompany to host...

Read more

Telomir Pharmaceuticals Special Advisor Dr. Michael Roizen to Discuss Telomir-1 and the Science of Longevity on Health Uncensored With Dr. Drew on the Fox Business Network This Sunday

September 26, 2024 4:00 PM

Interview to Air Sunday, September 29, 2024 at 5:30 PM EST on Fox Business NetworkMIAMI, FL / ACCESSWIRE / September 26, 2024 / Telomir Pharmaceuticals (NASDAQ:TELO) ("Telomir" or the "Company"), a preclinical-stage biotechnology company seeking to lead developments in longevity science through the treatment of age-related conditions, is proud to announce that the Telomir will be featured on Health Uncensored with Dr. Drew this Sunday, September...

Read more

Los Angeles Medical Waste Disposal Company Responds to Rise in Needlestick Injuries With In-Depth Guide

September 26, 2024 1:11 PM

The CDC reports that healthcare workers in the U.S. face an estimated 385,000 needlestick and sharps-related injuries every year.LOS ANGELES, CA / ACCESSWIRE / September 26, 2024 / Responding to the growing concern regarding needlestick injuries, BioMedical Waste Solutions, a leading medical waste disposal company with locations in Los Angeles, CA, is proactively informing the community about the risks of incorrect medical waste disposal,...

Read more

Enlighta Inc. Announces Resignation of Director and President

September 26, 2024 1:00 PM

RICHMOND, BC / ACCESSWIRE / September 26, 2024 / Enlighta Inc. (NEX:NLTA.H) announces today that Norman Tsui, a founder and President and long-time director of the company, has resigned from his position effective immediately. Norman has been with Enlighta since its inception in 2010 and played a pivotal role in the company's initial foundations, including the financing, development of its early technology, and the successful public listing on...

Read more

Gruber Plastic Surgery's Guide: Choosing the Right Cosmetic Procedure for Best Results

September 26, 2024 11:15 AM

Dr. Meegan Gruber offers patients a complete consultation to help them make the ideal decision.TAMPA, FL / ACCESSWIRE / September 26, 2024 / Anyone exploring the best cosmetic procedure should look for a surgeon certified by the American Board of Plastic Surgery (ABPS), which reflects extensive training and expert guidance in complex plastic surgery-specific procedures. Dr. Meegan Gruber, Ph.D., a leading board-certified plastic surgeon with...

Read more

Quest Diagnostics Amplifies Community Impact With Enhanced Corporate Giving Program and Record Employee Volunteerism in 2023

September 26, 2024 11:05 AM

NORTHAMPTON, MA / ACCESSWIRE / September 26, 2024 / Quest DiagnosticsOriginally published in Quest Diagnostics' 2023 Corporate Responsibility ReportQuest's Corporate Giving Program captures the passion and commitment of our workforce to make meaningful contributions to the communities where we live and operate through a combination of financial support, donated and discounted services, and volunteer time.EMPLOYEE VOLUNTEERISMQuest supported our...

Read more

Jaguar Health Scientific Advisory Board Member to Share Poster Presentation at American Society of Clinical Oncology (ASCO) Quality Care Symposium About the Methodologies Involved in Designing an Advocate-Led Quality of Life Survey for Cancer Patients and Survivors

September 26, 2024 10:00 AM

Jaguar Health, Inc. (NASDAQ:JAGX) today announced that Stacey Tinianov, MPH, the founder of Advocates for Collaborative Education (ACE) and a member of Jaguar's Scientific Advisory Board, will conduct a poster presentation on September 27, 2024 at the American Society of Clinical Oncology (ASCO) Quality Care Symposium. The presentation, titled "Measuring what really matters: Advocacy-led co-creation and accrual of a pan-cancer QoL survey," will...

Read more

MediVera Compounding Pharmacy(TM) Expands into 18 States Across Five Regions in 2024, Now Offers Dozens of Personalized Medicine Options

September 26, 2024 9:45 AM

TROY, MI / ACCESSWIRE / September 26, 2024 / MediVera Compounding Pharmacy™, a leader in personalized medicine since 1999, announced today that it has officially been licensed to serve residents in 18 new states across the West, Southwest, Southeast, Midwest, and Northeast regions in 2024. The licenses allow MediVera to fill compounding prescriptions-including semaglutide and tirzepatide-throughout these states. This expansion broadens the...

Read more